Correction Notice of Palisade Bio’s Press Release Announcing the Appointment of Clinical Advisory Board Members

February 8, 2024

https://www.globenewswire.com/news-release/2024/02/08/2826400/0/en/Correction-Notice-of-Palisade-Bio-s-Press-Release-Announcing-the-Appointment-of-Clinical-Advisory-Board-Members.html

Carlsbad, CA, Feb. 08, 2024 (GLOBE NEWSWIRE) — Palisade Bio, Inc.  (Nasdaq:PALI) (“Palisade” or the “Company”), a biopharmaceutical company focused on developing novel therapeutics for serious chronic gastrointestinal (GI) diseases, today announced a correction to its press release originally issued on February 8, 2024, announcing the appointments of Bruce Sands, MD, MS and Florian Rieder, MD to its Clinical Advisory Board (CAB).

Read more at globenewswire.com

Related news for (PALI)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.